How to Optimize the Administration of Low-Dose Non-vitamin K Antagonist Oral Anticoagulants in Everyday Practice?
Author:
Open Access
- 31 October 2022
- journal article
- letter
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 26 (11) , 852-853
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-AnalysisThe Anatolian Journal of Cardiology, 2022
- Direct oral anticoagulants in patients with atrial fibrillation and liver cirrhosis: a single-center experiencePolish Heart Journal, 2021
- Laboratory assessment of the direct oral anticoagulants: who can benefit?Polish Heart Journal, 2021
- Efficacy and safety of non–vitamin K antagonist oral anticoagulants in very elderly patients with atrial fibrillation: a single-center experiencePolish Heart Journal, 2020
- Real-World Use of Apixaban for Stroke Prevention in Atrial FibrillationStroke, 2018